AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates

AnaptysBio, Inc. (ANAB) came out with a quarterly loss of $1.64 per share versus the Zacks Consensus Estimate of a loss of$ 1.54. This compares to loss of $1.58 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -6.49%. A quarter ago, it was expected that this company would post a loss of$ 1.74 per share when it actually produced a loss of $1.59, delivering a surprise of 8.62%.Over the last four quarters, the company has surpasse ...